Prostate Biopsy in Response to a Change in Nadir Prostate Specific Antigen of 0.4 ng/ml after Treatment with 5α-Reductase Inhibitors Markedly Enhances the Detection Rate of Prostate Cancer-Reference-Cited by-同舟云学术

Prostate Biopsy in Response to a Change in Nadir Prostate Specific Antigen of 0.4 ng/ml after Treatment with 5α-Reductase Inhibitors Markedly Enhances the Detection Rate of Prostate Cancer

Published:2012-09 Issue:3 Volume:188 Page:757-761
ISSN:0022-5347
Container-title:Journal of Urology
language:en
Short-container-title:Journal of Urology

Author:

Kaplan Steven A.¹,Lee Richard K.¹,Chung Doreen E.¹,Te Alexis E.¹,Scherr Douglas S.¹,Tewari Ash¹,Vaughan E. Darracott¹

Affiliation:

1. Weill Cornell Medical College, Cornell University, New York, New York

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Urology

Reference26 articles.

1. Incidence and clinical significance of false-negative sextant prostate biopsies;Rabbani;J Urol,1998

2. Systematic 5 region prostate biopsy is superior to sextant method for diagnosing carcinoma of the prostate;Eskew;J Urol,1997

3. The optimal systematic prostate biopsy scheme should include 8 rather than 6 biopsies: results of a prospective clinical trial;Presti;J Urol,2000

4. Extensive repeat transrectal ultrasound guided prostate biopsy in patients with previous benign sextant biopsies;Borboroglu;J Urol,2000

5. A comparative analysis of sextant and an extended 11-core multisite directed biopsy strategy;Babaian;J Urol,2000

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Benign Prostatic Hyperplasia;Journal of Urology;2022-11

2. Impact of 5α-Reductase Inhibitors on Disease Reclassification among Men on Active Surveillance for Localized Prostate Cancer with Favorable Features;Journal of Urology;2018-02

3. Preventing clinical progression and need for treatment in patients on active surveillance for prostate cancer;Current Opinion in Urology;2018-01

4. Medical Aspects of the Treatment of Lower Urinary Tract Symptoms/Benign Prostatic Hyperplasia: 5-Alpha Reductase Inhibitors;Lower Urinary Tract Symptoms and Benign Prostatic Hyperplasia;2018

5. Re: Interactions between Benign Prostatic Hyperplasia (BPH) and Prostate Cancer in Large Prostates: A Retrospective Data Review;Journal of Urology;2017-06